Oxford Asset Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Oxford Asset Management’s Portfolio ACAD Stock Details ACAD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-11,925	Closed	-$219K	–	468
2024 Q4	$219K	Buy	+11,925	New	+$192K	0.1%	329
2020 Q1	–	Sell	-34,476	Closed	-$1.48M	–	215
2019 Q4	$1.48M	Sell	34,476 -3,815	-10%	-$166K	0.04%	611
2019 Q3	$1.38M	Sell	38,291 -32,111	-46%	-$974K	0.03%	758
2019 Q2	$1.88M	Buy	70,402 +42,837	+155%	+$1.09M	0.04%	664
2019 Q1	$740K	Sell	27,565 -53,091	-66%	-$1.24M	0.02%	1068
2018 Q4	$1.3M	Buy	+80,656	New	+$1.57M	0.03%	711
2014 Q3	–	Sell	-25,561	Closed	-$573K	–	665
2014 Q2	$573K	Sell	25,561 -110,250	-81%	-$2.3M	0.02%	553
2014 Q1	$3.3M	Buy	+135,811	New	+$3.44M	0.1%	283

Other funds holding ACAD

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Point72 Asset Management

Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return

Assenagon Asset Management

Assenagon Asset Management Senningerberg, Luxembourg $77B AUM 50.57% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return